Seer, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Omid C. Farokhzad, with a market cap of $112.8M.
Common questions about Seer, Inc.
Seer, Inc. is scheduled to report earnings for Q1 2026 on May 12, 2026 after market close. Analysts estimate revenue of $3.4M.
Seer, Inc. has approximately 147 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.